HomeCompareAMYT vs PEP

AMYT vs PEP: Dividend Comparison 2026

AMYT yields 13.61% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $93.0K in total portfolio value· pulled ahead in Year 7
10 years
AMYT
AMYT
● Live price
13.61%
Share price
$14.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48.9K
Annual income
$3,165.25
Full AMYT calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — AMYT vs PEP

📍 PEP pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMYTPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMYT + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMYT pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMYT
Annual income on $10K today (after 15% tax)
$1,156.46/yr
After 10yr DRIP, annual income (after tax)
$2,690.46/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, PEP beats the other by $49,903.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMYT + PEP for your $10,000?

AMYT: 50%PEP: 50%
100% PEP50/50100% AMYT
Portfolio after 10yr
$95.4K
Annual income
$32,520.47/yr
Blended yield
34.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

AMYT
Analyst Ratings
5
Hold
Consensus: Hold
Price Target
$14.50
-1.4% upside vs current
Range: $14.50 — $14.50
Altman Z
0.0
Piotroski
3/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMYT buys
0
PEP buys
0
No recent congressional trades found for AMYT or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMYTPEP
Forward yield13.61%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$48.9K$141.9K
Annual income after 10y$3,165.25$61,875.67
Total dividends collected$22.3K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold
Analyst price target$14.50$172.43

Year-by-year: AMYT vs PEP ($10,000, DRIP)

YearAMYT PortfolioAMYT Income/yrPEP PortfolioPEP Income/yrGap
1$12,061$1,360.54$10,849$509.42+$1.2KAMYT
2$14,438$1,533.54$11,969$750.47+$2.5KAMYT
3$17,165$1,715.78$13,500$1,124.14+$3.7KAMYT
4$20,273$1,906.34$15,680$1,721.66+$4.6KAMYT
5$23,796$2,104.21$18,929$2,715.34+$4.9KAMYT
6$27,770$2,308.32$24,023$4,450.80+$3.7KAMYT
7← crossover$32,231$2,517.59$32,510$7,669.92$279.00PEP
8$37,219$2,730.91$47,709$14,093.60$10.5KPEP
9$42,771$2,947.15$77,415$28,083.48$34.6KPEP
10$48,930$3,165.25$141,922$61,875.67$93.0KPEP

AMYT vs PEP: Complete Analysis 2026

AMYTStock

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.

Full AMYT Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this AMYT vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMYT vs SCHDAMYT vs JEPIAMYT vs OAMYT vs KOAMYT vs MAINAMYT vs MOAMYT vs PMAMYT vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.